J. Virol.:microRNA-146a参与乙肝病毒感染中T细胞免疫应答与耐受

2013-07-03 中国科学院微生物研究所 中国科学院微生物研究所

T细胞免疫,特别是病毒特异性T细胞免疫在控制乙肝病毒感染和清除病毒中发挥核心作用,在慢性乙肝感染中,高浓度的病毒抗原长期作用是诱导T细胞免疫耐受和特异性T细胞耗竭的直接原因,T细胞免疫功能受损直接导致病毒持续性感染和病毒难以清除。但长期以来,乙肝慢性感染中T细胞抗病毒功能缺陷与免疫耐受的调控机制并不清楚,这阻碍了进一步设计有效的针对性免疫治疗方案和药物。 中科院微生物研究所孟颂东课题组研究发现

T细胞免疫,特别是病毒特异性T细胞免疫在控制乙肝病毒感染和清除病毒中发挥核心作用,在慢性乙肝感染中,高浓度的病毒抗原长期作用是诱导T细胞免疫耐受和特异性T细胞耗竭的直接原因,T细胞免疫功能受损直接导致病毒持续性感染和病毒难以清除。但长期以来,乙肝慢性感染中T细胞抗病毒功能缺陷与免疫耐受的调控机制并不清楚,这阻碍了进一步设计有效的针对性免疫治疗方案和药物。

中科院微生物研究所孟颂东课题组研究发现,在慢性乙肝患者T细胞中,microRNA-146a水平在病毒抗原和炎症因子的作用下明显上调,microRNA-146a的上调通过靶向Stat1显著抑制T细胞的抗病毒功能,这为揭示病毒感染导致T细胞功能受损和免疫耐受提供了阐释。

有趣的是,课题组还发现乙肝病毒核心蛋白在60位氨基酸由亮氨酸突变为缬氨酸时会产生一个新的T细胞表位,同时导致病毒复制水平明显增加。通过临床资料分析发现,该位点突变导致乙肝患者病毒水平和肝脏免疫损伤均急剧升高,提示T细胞免疫应答、病毒复制和肝脏病理损伤三者存在复杂相互作用。

以上研究为揭示乙肝慢性感染中T细胞免疫耐受与T细胞介导的“旁观”效应引发肝损伤提供了新的机制,为进一步了解乙肝感染T细胞免疫应答机制和新型药物设计提供了依据。

成果分别发表在Journal of Immunology (191:193-301, 2013)和Journal of Virology (doi:10.1128/JVI.00577-13, 2013)。 

生物谷推荐的英文摘要
 

Current Issue

Journal of Virology  doi:10.1128/JVI.00577-13, 2013

The L60V variation in HBV core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication

Yu Zhang, Yulin Ren, Yan Wu, Bao Zhao, Lipeng Qiu, Xiaodong Li, Dongping Xu, Jun Liu, George F. Gao1 and Songdong Meng

Mutations in the core protein (HBc) of hepatitis B virus (HBV) are associated with aggressive hepatitis and advanced liver diseases in chronic hepatitis B (CHB). In this study, we identified the L60V variation in HBc that generates a new HLA-A2-restricted CD8+ T cell epitope by screening an overlapping 9-mer peptide pool covering HBc and its variants. The nonameric epitope V60 were determined by structural and immunogenic analysis. The HBc L60V variation is correlated with hepatic necroinflammation and higher viral levels, and it may be associated with poor prognosis in CHB patients. Immunization with the defined HBV epitope V60 peptide elicited specific cytotoxic T lymphocyte (CTL)-induced liver injury in HLA-A2+/HBV transgenic mice. In addition, in vitro and in vivo experiments both demonstrated that the HBc L60V variation facilitates viral capsid assembly and increases HBV replication. These data suggest that the HBc L60V variation can impact both HBV replication and HBV-specific T cell responses. Therefore, our work provides further dissection of the impact of the HBc L60V variation, which orchestrates HBV replication, viral persistence, and immunopathogenesis during chronic viral infection.

(责任编辑:lili.zhao)

分享到:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
    2013-08-02 xjy02
  4. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1793396, encodeId=0d551e93396ea, content=<a href='/topic/show?id=04fd15533ef' target=_blank style='color:#2F92EE;'>#RNA-146#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15533, encryptionId=04fd15533ef, topicName=RNA-146)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Jul 16 17:45:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857300, encodeId=422f185e300b4, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Nov 08 15:45:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084083, encodeId=cc9d208408361, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 02 04:45:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077329, encodeId=894320e73293d, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Tue Dec 17 10:45:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400204, encodeId=4f4e140020447, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407556, encodeId=9ccc140e55621, content=<a href='/topic/show?id=f150e779256' target=_blank style='color:#2F92EE;'>#细胞免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77792, encryptionId=f150e779256, topicName=细胞免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9362684728, createdName=tulenzi, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435655, encodeId=49c4143565570, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 05 12:45:00 CST 2013, time=2013-07-05, status=1, ipAttribution=)]
    2013-07-05 zhouqu_8

相关资讯

PLoS Negl Trop Dis:低温可降低蚊子免疫力 使其对某些病毒更加易感

近日,刊登在国际杂志PLoS Neglected Tropical Diseases上的一篇研究报告中,来自弗吉尼亚理工学院的研究者通过研究表明,当蚊子处于低温条件下后,其机体免疫力会变弱,这就使得其对危险的病毒更加易感,而且有可能将这些易感病毒传染给人类。 研究者Myles表示,我们的研究数据提出了一种合理的假说,就是天气的变化如何影响疾病的传播。随着全球气候的变化,多样的天气随时都会发生。本

New Scientist:科学家称裸鼹鼠体内神秘物质具有癌症免疫性

据英国新科学家杂志报道,如果与裸鼹鼠的身体大小作为参照对比,人类的寿命将达到600岁。与老鼠体型接近的裸鼹鼠生活在非洲的地下环境,它们的寿命可达到30岁。令科学家感到兴趣的是,这种丑陋的哺乳动物不会患癌症,目前,科学家最新研究揭晓了它们不会患有癌症的秘密,这将对治疗癌症患者提供了重要线索。 科学家最新研究揭晓了裸鼹鼠癌症免疫性的秘密,体内高分子质量透明质酸(HMM-HA)可阻止肿瘤细胞生长 美

JID:H5 DNA初免可增强H5N1流感疫苗免疫效果

大规模接种疫苗是减少流感流行的最有效方法。已有研究显示,预防季节性流感的DNA疫苗在小鼠中具有免疫原性,能够产生针对流感病毒的交叉性保护性抗体。此外,在人体中,当注射灭活流感疫苗24周前用H5 DNA初免能够增强抗体的反应,而间隔4周则没有作用。 为了研究在注射H5N1 单价灭活疫苗(MIV)前使用H5 DNA初免对抗体的产量、广度和亲和力的影响,来自美国食品和药物管理局(FDA)的Surend

Immunity & Ageing:免疫系统衰老慢令女性更长寿

女性为何普遍比男性更长寿?一项最新研究成果显示,女性的免疫系统衰老速度较慢,这可能是令女性寿命更长的一大优势。 日本研究人员5月15日在英国《免疫与衰老》杂志上报告说,他们追踪了356名20岁至90岁健康男女的血液情况,特别是随着年龄增长,这些人血液中与免疫有关的白细胞和细胞因子水平的变化情况。 结果发现,虽然在衰老过程中白细胞总数都会下降,但男性白细胞中的T细胞和B细胞等淋巴细胞减少速度明显

JID:H5 DNA初免联合H5N1单价灭活疫苗加强免疫可增强抗体反应

尽管有疫苗的存在,但流感仍然是全球性的公共健康问题之一,因此发展更好的能诱导稳定和广谱免疫的免疫策略仍十分重要。高致病性病毒株,如H5是一个更大的难题,它的传播性多样化,而且H5抗原的免疫原性低,人类一旦被感染,疾病的严重性和死亡率特别高。DNA流感疫苗能够诱导交叉性中和抗体,在临床试验中其中一部分能够直接与HA上的保守区域反应,而在动物模型中对多种流感的感染具有保护作用。此外,H5 DNA初免能

ASCO 2013:影像学无益于诊断侵袭性淋巴瘤复发

  梅奥诊所的一项研究发现,弥漫性大B细胞性淋巴瘤治疗后行影像学扫描无助于检测复发。研究者说,绝大多数罹患此侵袭性淋巴瘤的患者在复发时已有症状,他们的体格检查或血液检查结果异常。该发现将于3月31日-6月4日在芝加哥的美国临床肿瘤学会的年度会议上公布。   “我们的结果令人惊讶,因为目前的该疾病的护理标准包括随访时扫描,”第一作者Carrie Thompson(医学博士,梅奥诊所血液病学家)说。